AbbVie Considers Ending Shire Deal on Tax Rule

Oct. 15 (Bloomberg) -- AbbVie Inc. is considering scrapping the planned 32.4-billion-pound ($51.5 billion) acquisition of drugmaker Shire Plc in what would be the biggest casualty of the U.S. crackdown on so-called tax inversions. Matthew Campbell reports on Bloomberg Television's "The Pulse" with Guy Johnson. (Source: Bloomberg)

CalSTRS Ailman Sees European Growth, Upside Potential
19:43 - Chris Ailman, chief investment officer at CalSTRS, talks about the positives he sees in European markets and economic growth. He speaks on "Bloomberg Surveillance." (Source: Bloomberg)
  • SocGen's Bini Smaghi Wants European Banks to Be Larger
  • Trump, GOP Turn to Taxes as Latest Health Bill Dies
  • Intesa CEO Messina on Italian Banks, Consolidation